4.3 Article

Biplanar MRI for the assessment of the spinal cord in multiple sclerosis

Journal

MULTIPLE SCLEROSIS JOURNAL
Volume 18, Issue 11, Pages 1560-1569

Publisher

SAGE PUBLICATIONS LTD
DOI: 10.1177/1352458512442754

Keywords

multiple sclerosis; biplanar MRI; spinal cord

Funding

  1. GlaxoSmithKline
  2. Swiss MS Society
  3. Acorda
  4. Actelion
  5. Allozyne
  6. BaroFold
  7. Bayer HealthCare Pharmaceuticals
  8. Bayer Schering
  9. Bayhill
  10. Biogen Idec
  11. Boehringer Ingelheim
  12. Elan
  13. Genmab
  14. Glenmark
  15. Merck Serono
  16. Medicinova
  17. Novartis
  18. sanofiaventis
  19. Santhera
  20. Shire
  21. Roche
  22. TEVA
  23. UCB
  24. Wyeth
  25. Swiss National Research Foundation
  26. European Union
  27. Gianni Rubatto Foundation
  28. Novartis Research Foundation
  29. Roche Research Foundation
  30. TEVA Neurosciences

Ask authors/readers for more resources

Objective: To investigate the entire spinal cord (SC) of multiple sclerosis (MS) patients with biplanar MRI and to relate these MRI findings to clinical functional scores. Methods: Two hundred and two patients (140 women, 62 men 24-74 years, Expanded Disability Status Scale (EDSS) scores 0-7.5) were investigated clinically and with biplanar MRI. Sagittal and axial proton density weighted (PDw) and T2 weighted (T2w) images of the whole SC were obtained employing parallel imaging. Data were analyzed by consensus reading using a standardized reporting scheme. Different combinations of findings were compared to EDSS scores with Spearman's rank correlation coefficient (rho). Results: The combined analysis of sagittal and axial planes demonstrated slightly differing results in 97/202 (48%) patients. There were 9% additional lesions identified, leading to a higher lesion count in 28% of these patients, but also rejection of equivocal abnormality leading to a lower lesion count in 11% of patients. Considering both sagittal and axial images, SC abnormalities were found in 167/202 (83%) patients. When compared with EDSS scores, the combination of focal lesions, signs of atrophy and diffuse abnormalities showed a moderate correlation (rho=0.52), that precludes its use for individual patient assessment. Conclusion: Biplanar MRI facilitates a comprehensive identification, localization, and grading of pathological SC findings in MS patients. This improves the confidence and utility of SC imaging.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available